• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术切缘对肝内胆管细胞癌患者预后的影响:AFC-IHCC-2009 研究组的多中心研究。

Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group.

机构信息

Department of Hepatobiliary Surgery, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, AP-HP, Université Paris 7, Clichy, France.

出版信息

Ann Surg. 2011 Nov;254(5):824-29; discussion 830. doi: 10.1097/SLA.0b013e318236c21d.

DOI:10.1097/SLA.0b013e318236c21d
PMID:22042474
Abstract

OBJECTIVE

Define the optimal surgical margin in patients undergoing surgery for intrahepatic cholangiocarcinoma (IHCC).

BACKGROUND DATA

Surgery is the most effective treatment for IHCC. However, the influence of R1 resection on outcome is controversial and that of margin width has not been evaluated.

METHODS

We studied 212 patients undergoing curative resection of mass-forming-type IHCC. The respective influences on survival of resection status (R0 vs R1), surgical margin width, pTNM stage, and the latter's components were evaluated.

RESULTS

Incidence of R1 resection was 24%. Overall, R1 resection was not an independent predictor of survival [odds ratio (OR) 1.2 (0.7-2.1)] in contrast to the pTNM stage [OR 2.10 (1.2-3.5)]. In the 78 pN+ patients, survival was similar after R0 and R1 resections (median: 18 vs 13 months, respectively, P = 0.1). In the 134 pN0 patients, R1 resection was an independent predictor of poor survival [OR 9.6 (4.5-20.4)], as was the presence of satellite nodules [OR 1.9 (1.1-3.2)]. In the 116 pN0 patients with R0 resections, median survival was correlated with margin width (≤1 mm: 15 months; 2-4 mm: 36 months; 5-9 mm: 57 month; ≥10 mm: 64 month, P < 0.001) and a margin >5 mm was an independent predictor of survival [OR 2.22 (1.59-3.09)].

CONCLUSION

Patients undergoing surgery for IHCC are at high risk of R1 resections. In pN0 patients, R1 resection is the strongest independent predictor of poor outcome and a margin of at least 5 mm should be created. The survival benefits of resection in pN+ patients and R1 resection in general are very low.

摘要

目的

确定肝内胆管细胞癌(intrahepatic cholangiocarcinoma,IHCC)患者手术中最佳的手术切缘。

背景资料

手术是治疗 IHCC 最有效的方法。然而,R1 切除对预后的影响仍存在争议,而切缘宽度的影响尚未得到评估。

方法

我们研究了 212 例行肿块型 IHCC 根治性切除术的患者。评估了切除状态(R0 与 R1)、手术切缘宽度、pTNM 分期及其组成部分对生存的各自影响。

结果

R1 切除的发生率为 24%。整体而言,与 pTNM 分期相比(OR 2.10[1.2-3.5]),R1 切除不是生存的独立预测因素(OR 1.2[0.7-2.1])。在 78 例 pN+患者中,R0 与 R1 切除后的生存情况相似(中位生存时间:分别为 18 个月和 13 个月,P=0.1)。在 134 例 pN0 患者中,R1 切除是生存较差的独立预测因素(OR 9.6[4.5-20.4]),卫星结节的存在也是如此(OR 1.9[1.1-3.2])。在 116 例接受 R0 切除的 pN0 患者中,中位生存时间与切缘宽度相关(≤1mm:15 个月;2-4mm:36 个月;5-9mm:57 个月;≥10mm:64 个月,P<0.001),且切缘>5mm 是生存的独立预测因素(OR 2.22[1.59-3.09])。

结论

接受 IHCC 手术的患者 R1 切除的风险较高。在 pN0 患者中,R1 切除是预后不良的最强独立预测因素,应创建至少 5mm 的切缘。pN+患者的手术切除和总体上的 R1 切除的生存获益非常低。

相似文献

1
Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group.手术切缘对肝内胆管细胞癌患者预后的影响:AFC-IHCC-2009 研究组的多中心研究。
Ann Surg. 2011 Nov;254(5):824-29; discussion 830. doi: 10.1097/SLA.0b013e318236c21d.
2
Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma.术中近端胆管切缘阳性的额外切除可改善肝门部胆管癌患者的生存。
Ann Surg. 2011 Nov;254(5):776-81; discussion 781-3. doi: 10.1097/SLA.0b013e3182368f85.
3
Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.肝切除切缘对肝内胆管癌复发和生存的影响。
Ann Surg Oncol. 2008 Oct;15(10):2787-94. doi: 10.1245/s10434-008-0081-1. Epub 2008 Aug 7.
4
Single centre experience with surgical treatment of hilar cholangiocarcinoma.肝门部胆管癌手术治疗的单中心经验
Chirurgia (Bucur). 2013 May-Jun;108(3):299-303.
5
Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.184例肝门部胆管癌患者的手术及姑息治疗与结局:姑息性光动力疗法联合支架置入与R1/R2切除效果相当。
Ann Surg. 2006 Aug;244(2):230-9. doi: 10.1097/01.sla.0000217639.10331.47.
6
Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.切除与经肝动脉化疗栓塞治疗进展期肝内胆管细胞癌的疗效比较——单中心经验
Eur J Surg Oncol. 2013 Jun;39(6):593-600. doi: 10.1016/j.ejso.2013.03.010. Epub 2013 Apr 20.
7
Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.肝外胆管癌切除术患者中,胆管切缘状态对长期生存的影响。
Cancer. 2005 Mar 15;103(6):1210-6. doi: 10.1002/cncr.20906.
8
Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.肝门部胆管癌切除术:同期肝切除可降低肝内复发率。
Ann Surg. 2008 Aug;248(2):273-9. doi: 10.1097/SLA.0b013e31817f2bfd.
9
Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.肿块型肝内胆管癌的组织学胆管侵犯
J Hepatobiliary Pancreat Surg. 2002;9(2):233-6. doi: 10.1007/s005340200024.
10
Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.肝门部胆管癌的预后:肝门部胆管癌与累及肝门的肝内胆管癌
Ann Surg Oncol. 2008 Feb;15(2):590-9. doi: 10.1245/s10434-007-9687-y. Epub 2007 Dec 5.

引用本文的文献

1
Role of Particle Therapy for Intrahepatic Cholangiocarcinoma; Meta-Analysis for Comparison with Standard Therapy: TRP-Intrahepatic Cholangiocarcinoma 2025.粒子治疗在肝内胆管癌中的作用;与标准治疗比较的荟萃分析:TRP-肝内胆管癌2025
Liver Cancer. 2025 Jun 22. doi: 10.1159/000546559.
2
Therapeutic Advances in Initially Unresectable Locally Advanced Intrahepatic Cholangiocarcinoma: Emerging Treatments and the Role of Liver Transplantation.初治不可切除的局部晚期肝内胆管癌的治疗进展:新兴治疗方法及肝移植的作用
Curr Oncol. 2025 May 22;32(6):293. doi: 10.3390/curroncol32060293.
3
Intrahepatic cholangiocarcinoma: Insights on molecular testing, targeted therapies, and future directions from a multidisciplinary panel.
肝内胆管癌:多学科专家小组对分子检测、靶向治疗及未来方向的见解
Hepatol Commun. 2025 Jun 9;9(7). doi: 10.1097/HC9.0000000000000743. eCollection 2025 Jul 1.
4
Intrahepatic cholangiocarcinoma: role of imaging as a critical component for multi-disciplinary treatment approach.肝内胆管癌:影像学作为多学科治疗方法关键组成部分的作用
Abdom Radiol (NY). 2025 Mar 17. doi: 10.1007/s00261-025-04856-5.
5
LI-RADS Category Can Be a Post-Surgical Prognostic Factor for Intrahepatic Cholangiocarcinoma in Patients with Liver Cirrhosis or Chronic Hepatitis B.肝脏影像报告和数据系统(LI-RADS)分类可作为肝硬化或慢性乙型肝炎患者肝内胆管癌的术后预后因素。
Liver Cancer. 2024 Jun 14;13(6):629-642. doi: 10.1159/000539794. eCollection 2024 Dec.
6
Mass-forming intrahepatic cholangiocarcinoma: treatment outcomes after curative-intent resection in an Australian tertiary referral hospital.肿块型肝内胆管癌:澳大利亚一家三级转诊医院根治性切除术后的治疗结果
ANZ J Surg. 2025 May;95(5):934-941. doi: 10.1111/ans.19326. Epub 2024 Dec 6.
7
Anatomic Versus Non-anatomic Liver Resection for Intrahepatic Cholangiocarcinoma: A Systematic Review and Patient-Level Meta-Analysis.解剖性肝切除术与非解剖性肝切除术治疗肝内胆管细胞癌:系统评价和患者水平的荟萃分析。
Ann Surg Oncol. 2024 Dec;31(13):9170-9182. doi: 10.1245/s10434-024-16121-y. Epub 2024 Sep 9.
8
Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation.胆管癌:包括肝移植在内的手术选择现状
Cancers (Basel). 2024 May 21;16(11):1946. doi: 10.3390/cancers16111946.
9
The Clinical Association Between the Inflammation-Nutritional Condition and Prognosis of Locally Advanced Intrahepatic Cholangiocarcinoma After R0 Resection: Evidence from Competing Risk and Propensity Matching Analysis.R0切除术后局部晚期肝内胆管癌炎症-营养状况与预后的临床关联:来自竞争风险和倾向匹配分析的证据
J Inflamm Res. 2024 May 7;17:2787-2799. doi: 10.2147/JIR.S460103. eCollection 2024.
10
Recommendations on maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinoma.关于在肝内胆管癌患者管理中最大化组织临床价值的建议。
JHEP Rep. 2024 Mar 12;6(6):101067. doi: 10.1016/j.jhepr.2024.101067. eCollection 2024 Jun.